Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 May;84(9):1188–1192. doi: 10.1054/bjoc.2000.1709

Breast cancer and NSAID use: a meta-analysis

S A Khuder 1, A B Mutgi 1
PMCID: PMC2363879  PMID: 11336469

Abstract

Recent epidemiological studies suggest that non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of several cancers including breast cancer. This meta-analysis examined the studies on NSAID use and breast cancer. The estimators of relative risk and associated variances, which have been adjusted for the greatest number of confounders, were abstracted and included in the meta-analysis. Combined estimators of relative risk (RR) were calculated using either fixed or random effect models. Meta-analyses were performed on 6 cohort studies (number of cases ranged from 14 to 2414) and 8 case–control studies (number of cases ranged from 252 to 5882). The combined estimate of relative risk was 0.82 (95% confidence interval [CI] = 0.75–0.89). The combined estimate for cohort studies was 0.78 (95% CI = 0.62–0.99) and was 0.87 (95% CI = 0.84–0.91) for case–control studies. The findings of this meta-analysis suggest that NSAID use may be associated with a small decrease in the risk of breast cancer. However, the available data are insufficient to estimate the dose–response effect for duration and frequency of use of any particular types of NSAID. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: NSAID; breast cancer; meta-analysis, females

Full Text

The Full Text of this article is available as a PDF (62.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron J. A. Aspirin and cancer. Prev Med. 1995 Mar;24(2):121–124. doi: 10.1006/pmed.1995.1023. [DOI] [PubMed] [Google Scholar]
  2. Begg C. B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 Dec;50(4):1088–1101. [PubMed] [Google Scholar]
  3. Carter C. A., Milholland R. J., Shea W., Ip M. M. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res. 1983 Aug;43(8):3559–3562. [PubMed] [Google Scholar]
  4. Coogan P. F., Rao S. R., Rosenberg L., Palmer J. R., Strom B. L., Zauber A. G., Stolley P. D., Shapiro S. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med. 1999 Aug;29(2):72–76. doi: 10.1006/pmed.1999.0518. [DOI] [PubMed] [Google Scholar]
  5. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  6. Dinse G. E., Umbach D. M., Sasco A. J., Hoel D. G., Davis D. L. Unexplained increases in cancer incidence in the United States from 1975 to 1994: possible sentinel health indicators? Annu Rev Public Health. 1999;20:173–209. doi: 10.1146/annurev.publhealth.20.1.173. [DOI] [PubMed] [Google Scholar]
  7. Egan K. M., Stampfer M. J., Giovannucci E., Rosner B. A., Colditz G. A. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst. 1996 Jul 17;88(14):988–993. doi: 10.1093/jnci/88.14.988. [DOI] [PubMed] [Google Scholar]
  8. Friedman G. D., Ury H. K. Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst. 1980 Oct;65(4):723–733. doi: 10.1093/jnci/65.4.723. [DOI] [PubMed] [Google Scholar]
  9. Gridley G., McLaughlin J. K., Ekbom A., Klareskog L., Adami H. O., Hacker D. G., Hoover R., Fraumeni J. F., Jr Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993 Feb 17;85(4):307–311. doi: 10.1093/jnci/85.4.307. [DOI] [PubMed] [Google Scholar]
  10. Harris R. E., Alshafie G. A., Abou-Issa H., Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res. 2000 Apr 15;60(8):2101–2103. [PubMed] [Google Scholar]
  11. Harris R. E., Kasbari S., Farrar W. B. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep. 1999 Jan-Feb;6(1):71–73. [PubMed] [Google Scholar]
  12. Harris R. E., Namboodiri K. K., Farrar W. B. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology. 1996 Mar;7(2):203–205. doi: 10.1097/00001648-199603000-00017. [DOI] [PubMed] [Google Scholar]
  13. Harris R. E., Namboodiri K., Stellman S. D., Wynder E. L. Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med. 1995 Mar;24(2):119–120. doi: 10.1006/pmed.1995.1022. [DOI] [PubMed] [Google Scholar]
  14. Hwang D., Scollard D., Byrne J., Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 1998 Mar 18;90(6):455–460. doi: 10.1093/jnci/90.6.455. [DOI] [PubMed] [Google Scholar]
  15. Kelsey J. L., Gammon M. D., John E. M. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47. doi: 10.1093/oxfordjournals.epirev.a036115. [DOI] [PubMed] [Google Scholar]
  16. Lala P. K., Al-Mutter N., Orucevic A. Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer. 1997 Nov 4;73(3):371–380. doi: 10.1002/(sici)1097-0215(19971104)73:3<371::aid-ijc12>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  17. Langman M. J., Cheng K. K., Gilman E. A., Lancashire R. J. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ. 2000 Jun 17;320(7250):1642–1646. doi: 10.1136/bmj.320.7250.1642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lupulescu A. Enhancement of carcinogenesis by prostaglandins. Nature. 1978 Apr 13;272(5654):634–636. doi: 10.1038/272634a0. [DOI] [PubMed] [Google Scholar]
  19. Lynch N. R., Castes M., Astoin M., Salomon J. C. Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Cancer. 1978 Oct;38(4):503–512. doi: 10.1038/bjc.1978.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Madigan M. P., Ziegler R. G., Benichou J., Byrne C., Hoover R. N. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995 Nov 15;87(22):1681–1685. doi: 10.1093/jnci/87.22.1681. [DOI] [PubMed] [Google Scholar]
  21. McCormick D. L., Wilson A. M. Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene. Cancer Res. 1986 Aug;46(8):3907–3911. [PubMed] [Google Scholar]
  22. Mellemkjaer L., Linet M. S., Gridley G., Frisch M., Møller H., Olsen J. H. Rheumatoid arthritis and cancer risk. Eur J Cancer. 1996 Sep;32A(10):1753–1757. doi: 10.1016/0959-8049(96)00210-9. [DOI] [PubMed] [Google Scholar]
  23. Neugut A. I., Rosenberg D. J., Ahsan H., Jacobson J. S., Wahid N., Hagan M., Rahman M. I., Khan Z. R., Chen L., Pablos-Mendez A. Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):869–873. [PubMed] [Google Scholar]
  24. Paganini-Hill A., Chao A., Ross R. K., Henderson B. E. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989 Nov 18;299(6710):1247–1250. doi: 10.1136/bmj.299.6710.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Robertson F. M., Parrett M. L., Joarder F. S., Ross M., Abou-Issa H. M., Alshafie G., Harris R. E. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas. Cancer Lett. 1998 Jan 9;122(1-2):165–175. doi: 10.1016/s0304-3835(97)00387-x. [DOI] [PubMed] [Google Scholar]
  26. Rosenberg L. Nonsteroidal anti-inflammatory drugs and cancer. Prev Med. 1995 Mar;24(2):107–109. doi: 10.1006/pmed.1995.1018. [DOI] [PubMed] [Google Scholar]
  27. Rosenberg L., Palmer J. R., Zauber A. G., Warshauer M. E., Stolley P. D., Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991 Mar 6;83(5):355–358. doi: 10.1093/jnci/83.5.355. [DOI] [PubMed] [Google Scholar]
  28. Schreinemachers D. M., Everson R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994 Mar;5(2):138–146. doi: 10.1097/00001648-199403000-00003. [DOI] [PubMed] [Google Scholar]
  29. Sharpe C. R., Collet J. P., McNutt M., Belzile E., Boivin J. F., Hanley J. A. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer. 2000 Jul;83(1):112–120. doi: 10.1054/bjoc.2000.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Symmons D. P. Neoplasia in rheumatoid arthritis. J Rheumatol. 1988 Sep;15(9):1319–1322. [PubMed] [Google Scholar]
  31. Thompson H. J., Briggs S., Paranka N. S., Piazza G. A., Brendel K., Gross P. H., Sperl G. J., Pamukcu R., Ahnen D. J. Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J Natl Cancer Inst. 1995 Aug 16;87(16):1259–1260. [PubMed] [Google Scholar]
  32. Thun M. J., Namboodiri M. M., Calle E. E., Flanders W. D., Heath C. W., Jr Aspirin use and risk of fatal cancer. Cancer Res. 1993 Mar 15;53(6):1322–1327. [PubMed] [Google Scholar]
  33. Wun L. M., Feuer E. J., Miller B. A. Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control. 1995 Mar;6(2):135–144. doi: 10.1007/BF00052774. [DOI] [PubMed] [Google Scholar]
  34. van Aswegen C., Dirksen van Schalkwyk J. C., Roux L. J., Becker P. J., Du Plessis D. J. A novel study on the effect of acetylsalicylic acid on the binding capacity of estrogen receptors from MCF-7 cells. Clin Physiol Biochem. 1992;9(4):145–149. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES